Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.

MLA

Han, Sh, et al. “Prognostic Significance of the Interval between the Initiation of Antiretroviral Therapy and the Initiation of Anti-Tuberculosis Treatment in HIV/Tuberculosis-Coinfected Patients: Results from the TREAT Asia HIV Observational Database.” HIV Medicine, vol. 15, no. 2, Feb. 2014, pp. 77–85. EBSCOhost, https://doi.org/10.1111/hiv.12073.

APA

Han, S., Zhou, J., Lee, M., Zhao, H., Chen, Y. ‐ M., Kumarasamy, N., Pujari, S., Lee, C., Omar, S., Ditangco, R., Phanuphak, N., Kiertiburanakul, S., Chaiwarith, R., Merati, T., Yunihastuti, E., Tanuma, J., Saphonn, V., Sohn, A., & Choi, J. (2014). Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database. HIV Medicine, 15(2), 77–85. https://doi.org/10.1111/hiv.12073

Chicago

Han, Sh, J Zhou, Mp Lee, H Zhao, Y ‐ Ma Chen, N Kumarasamy, S Pujari, et al. 2014. “Prognostic Significance of the Interval between the Initiation of Antiretroviral Therapy and the Initiation of Anti-Tuberculosis Treatment in HIV/Tuberculosis-Coinfected Patients: Results from the TREAT Asia HIV Observational Database.” HIV Medicine 15 (2): 77–85. doi:10.1111/hiv.12073.